Barclays PLC

NYSE:BCS Lagerbericht

Marktkapitalisierung: US$80.6b

Barclays Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Barclays wird ein jährliches Gewinn- und Umsatzwachstum von 8.9% bzw. 5.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 12.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12.3% betragen.

Wichtige Informationen

8.9%

Wachstumsrate der Gewinne

12.86%

EPS-Wachstumsrate

Banks Gewinnwachstum8.3%
Wachstumsrate der Einnahmen5.6%
Zukünftige Eigenkapitalrendite12.28%
Analystenabdeckung

Good

Zuletzt aktualisiert07 May 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Seeking Alpha Apr 13

Barclays: Interesting Fundamentals, But Challenges Are Being Underestimated

Summary Barclays PLC receives a "Hold" rating, reflecting limited risk-adjusted upside at current valuations. Recent share price recovery and consensus "Buy" ratings are challenged by concerns over high overheads, regulatory history, and reliance on buybacks for KPI improvement. 2025 results met guidance, but cost/income remains elevated (over 61%), yield is under 2%, and buybacks are driving much of the reported EPS and ROTE growth. I see Barclays as fundamentally sound but not attractively valued for growth. Significant upside depends on aggressive buybacks and optimistic efficiency gains. Read the full article on Seeking Alpha
Seeking Alpha Apr 25

Barclays: Deposit-To-Loan And Credit Cycle Obstacles Have Emerged

Summary Barclays' ADRs trade below book value despite a near 60% year-on-year increase. Although tempted by the asset, we think structural risks have emerged that could create a value trap. Net interest income faces headwinds due to softened deposits and stalled loan commitments, potentially impacting Barclays' financials by late 2025. Despite a strong liquidity coverage ratio and non-cyclical performance from wealth management, we think the bank's NII risk remains underestimated. The bank's dividend profile is commendable, and its price returns show an ability to create holistic shareholder value. However, max drawdown and VaR metrics show that cyclical declines are severe. We maintain a 'Hold' outlook on Barclays. Read the full article on Seeking Alpha
Seeking Alpha Feb 14

Barclays Q4 Results: Backing Out After 20%+ Gain

Summary Barclays PLC's Q4 results showed a 24.3% increase in total income, driven by strong performance in UK and Investment Banking, despite a 4% ADR drop. Concerns arise from Barclays UK's credit headwinds, declining mortgage rates, and rising delinquencies, impacting lending and depository environment. Investment Banking's future is uncertain, but potential M&A and IPO rebounds, along with fixed-income opportunities, could mitigate trading revenue risks. Given fundamental headwinds in UK consumer and corporate debt segments, I downgrade Barclays' ADRs from 'buy' to 'hold.'. Read the full article on Seeking Alpha
Seeking Alpha Dec 20

Barclays: Still Trading At 0.6x 2026 Book Value

Summary Barclays remains a high-conviction pick, outperforming peers in 2024, trading at ~0.6x 2026 TBV despite a 70% YTD increase. The bank targets a +12% RoTE by 2026, focusing on high-return UK segments and cost efficiency, driving current outperformance. Analysts projections expect Barclays to meet cost-income targets but fall short on RoTE due to lower revenue growth; current valuation reflects a discount to U.S. peers. Key risks include macroeconomic crises, litigation, and execution failures, but BCS' resilient business model and buyback program support a Strong Buy rating. Read the full article on Seeking Alpha
Seeking Alpha Nov 01

Barclays: On Track For Super-Charged Shareholder Returns

Summary Barclays stock is poised for significant upside, supported by strong Q3 results, a cheap valuation, and improving commercial momentum. The bank's Q3 performance exceeded expectations with strong revenue and earnings growth, highlighting operational discipline and strategic hedging initiatives. Barclays aims for £30 billion in revenue by 2026 and plans to return $10 billion to shareholders, promising substantial equity yield. I now estimate Barclays' U.S. ADR fair value at $33 per share, driven by revised EPS projections and an ongoing positive outlook for investment banking fees. Read the full article on Seeking Alpha
Seeking Alpha Oct 25

Barclays: Value Or Trap Following Q3 Earnings?

Summary Barclays PLC has shown improved financial performance in Q3 2024, but revenue and earnings growth may be challenging due to the expected declining interest rate environment. The bank's valuation remains low, trading at around 0.6x book value, reflecting structural issues and a more cyclical business mix compared to peers. Barclays' strategy includes streamlining operations, focusing on higher growth areas, and improving efficiency, but more aggressive steps are needed for a potential re-rating. Despite positive earnings and a strong capital position, Barclays' shares do not offer much value for long-term investors given current market conditions and profitability challenges. Read the full article on Seeking Alpha
Seeking Alpha Aug 28

Barclays: Still Undervalued With Fundamental Resilience

Summary Barclays PLC's stock price has surged since our latest coverage in October 2022, but a changing interest rate environment necessitates a revised outlook. Recent results show a decline in group income. I believe retail and corporate banking might underperform toward the back end of 2024 and early 2025. Despite my concerns about Barclays' net interest income, key metrics suggest that the firm's investment banking unit might spike. Moreover, private banking and wealth management can provide sustainable growth. A residual income model deems Barclays' stock undervalued, and a bird's-eye observation suggests the bank's dividend profile is respectable. Read the full article on Seeking Alpha
Seeking Alpha Aug 12

Barclays: Heading In The Right Direction

Summary Barclays reported a solid set of 2Q24 numbers, upgrading FY24E net interest income guidance and announcing a further £750m share buyback. Management is happy with the early progress towards the FY26 financial targets announced earlier this year. Consensus forecasts for FY26E imply significant share price upside, but should be taken with a healthy pinch of salt. The Barclays share price has performed well in recent months and has sufficient potential for further gains to support the maintenance of a Buy rating. Read the full article on Seeking Alpha
Seeking Alpha May 20

Barclays: Well On Track To Deliver On The Triple-Digit Upside

Summary Barclays delivered a solid set of Q1 results, generating £7.0 billion in revenues, and £2.3 billion in pre-tax profits after impairment. Together with Q1 results, Barclays also shared a corporate strategy update and guided for a ROTE of >10% in 2024 and <12% in 2025. If ROTE guidance is correct, then BCS shares are undoubtedly cheap at about 0.5 P/B, and the stock may deserve a re-rating. The thesis of a cheap valuation is further underscored by Barclays' ambition to return about $12.5 billion of capital to investors over the next 3 years. I reiterate a "Strong Buy" rating for BCS shares, while I raise my base case target price to $29.5. Read the full article on Seeking Alpha

Gewinn- und Umsatzwachstumsprognosen

NYSE:BCS - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (GBP Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/202833,8809,009N/AN/A14
12/31/202732,4898,257N/AN/A15
12/31/202631,0197,161N/AN/A15
3/31/202627,0926,243N/AN/AN/A
12/31/202526,8186,175-8,070-6,211N/A
9/30/202526,0165,945N/AN/AN/A
6/30/202525,6546,052-11,890-10,316N/A
3/31/202524,8765,630N/AN/AN/A
12/31/202424,2505,316-9,413-7,839N/A
9/30/202423,5994,240N/AN/AN/A
6/30/202423,2513,9508,2289,946N/A
3/31/202423,2244,041N/AN/AN/A
12/31/202323,4974,2744,3136,031N/A
9/30/202323,7545,421N/AN/AN/A
6/30/202323,4995,6594,1115,857N/A
3/31/202324,0945,402N/AN/AN/A
12/31/202223,7365,0232,1363,882N/A
9/30/202223,6245,066N/AN/AN/A
6/30/202223,4004,9282,7384,458N/A
3/31/202223,1035,905N/AN/AN/A
12/31/202122,5936,2058,80210,522N/A
9/30/202121,9835,346N/AN/AN/A
6/30/202121,2204,5835,9787,302N/A
3/31/202118,7372,625N/AN/AN/A
12/31/202016,9451,526-9,068-7,744N/A
9/30/202017,2671,987N/AN/AN/A
6/30/202017,7541,0846,5368,329N/A
3/31/202019,0942,028N/AN/AN/A
12/31/201919,7302,461N/A-21,451N/A
9/30/201919,4721,766N/AN/AN/A
6/30/201919,2653,108N/A-32,703N/A
3/31/201919,5023,399N/AN/AN/A
12/31/201819,6681,597N/A-14,780N/A
9/30/201819,869366N/AN/AN/A
6/30/201819,47056N/A21,836N/A
3/31/201818,701-1,206N/AN/AN/A
12/31/201718,927587N/A55,473N/A
9/30/201719,0552,021N/AN/AN/A
6/30/201719,8901,642N/A-19,710N/A
3/31/201720,5162,215N/AN/AN/A
12/31/201619,8181,562N/A-31,695N/A
9/30/201617,820-1,242N/AN/AN/A
6/30/201617,713-1,064N/A52,308N/A
3/31/201618,479-691N/AN/AN/A
12/31/201519,641-626N/A46,633N/A
9/30/201520,254194N/AN/AN/A
6/30/201521,102185N/A2,782N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: BCSDas prognostizierte Gewinnwachstum (8.9% pro Jahr) liegt über der Sparquote (3.5%).

Ertrag vs. Markt: BCSDie Erträge des Unternehmens (8.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (16.7% pro Jahr).

Hohe Wachstumserträge: BCSDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: BCSDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.6% pro Jahr).

Hohe Wachstumseinnahmen: BCSDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: BCSDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12.3%).


Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/11 17:26
Aktienkurs zum Tagesende2026/05/08 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Barclays PLC wird von 29 Analysten beobachtet. 15 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Jesús Gómez DominguezBanco Santander
Peter RichardsonBerenberg
Dirk Hoffmann-BeckingBernstein